Randomized Controlled Trial
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. May 27, 2024; 16(5): 1377-1384
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1377
Table 1 Baseline characteristics of the two groups

Treatment group (n = 64)
Control group (n = 64)
P value
Age (yr)46.3 ± 11.245.6 ± 10.80.68
Sex (male/female)32/3233/310.82
Body mass index (kg/m2)23.5 ± 3.223.7 ± 3.40.76
Duration of disease (months)27.4 ± 15.626.8 ± 16.20.84
Helicobacter pylori status (positive/negative)38/2637/270.88
NDI score42.7 ± 8.943.1 ± 9.20.79
MLS score6.4 ± 2.16.5 ± 2.20.87
USS score9.3 ± 3.49.5 ± 3.60.81
Microcosmic syndrome score12.6 ± 4.812.8 ± 4.90.83